iShares Biotechnology ETF Rating $139.73 -0.63 (-0.45%) As of 01:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.67Holdings in IBB have an aggregate rating of Moderate Buy based on 484 analyst ratings issued in the past year covering 25 companies (69.6% of the portfolio).IBB Aggregate Price Target$139.530.15% UpsideHigh Prediction$139.53Average Prediction$139.53Low Prediction$139.53Holdings in IBB have an aggregate price target of $139.53 and a range of $139.53 to $139.53 covering 25 companies (69.6% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.49%GILDGilead Sciences$112.79-0.2%4.9797 of 5 stars2.88$115.39 2.3%26Positive News7.29%AMGNAmgen$279.89-1.4%4.6533 of 5 stars2.32$304.43 8.8%22Positive NewsAnalyst Forecast6.76%REGNRegeneron Pharmaceuticals$564.98+0.2%4.8448 of 5 stars2.81$817.67 44.7%27Positive NewsAnalyst Upgrade6.38%VRTXVertex Pharmaceuticals$395.55-0.3%4.9826 of 5 stars2.56$497.10 25.7%27Positive NewsAnalyst Forecast6.33%ALNYAlnylam Pharmaceuticals$454.34+1.5%3.97 of 5 stars2.85$412.79 -9.1%26News CoveragePositive NewsAnalyst Forecast3.45%IQVIQVIA$182.07-1.4%4.9811 of 5 stars2.74$229.86 26.2%23Positive NewsAnalyst Forecast2.87%MTDMettler-Toledo International$1,275.85+0.6%4.2875 of 5 stars2.50$1,311.11 2.8%10Positive News2.77%ARGXargenex$733.20+1.5%4.094 of 5 stars3.09$772.84 5.4%23Analyst Forecast2.56%INSMInsmed$142.10-1.0%3.7647 of 5 stars2.94$134.79 -5.1%17Trending NewsAnalyst ForecastAnalyst Revision2.27%NTRANatera$167.93+0.2%3.179 of 5 stars3.06$194.00 15.5%18Positive NewsAnalyst ForecastInsider Trade2.21%BIIBBiogen$138.31-2.3%4.9021 of 5 stars2.34$185.74 34.3%32Trending NewsAnalyst Forecast1.90%ONCBeOne Medicines$321.82-4.3%0.9642 of 5 stars3.00$330.89 2.8%7Gap Down1.87%WATWaters$299.50+3.3%4.7011 of 5 stars2.47$378.73 26.5%15Trending News1.80%BNTXBioNTech$102.60+2.2%1.9431 of 5 stars2.76$135.80 32.4%171.79%INCYIncyte$85.80-1.3%4.6548 of 5 stars2.33$81.60 -4.9%18News CoveragePositive NewsShort Interest ↑1.66%ILMNIllumina$96.54+0.5%4.9195 of 5 stars2.21$123.06 27.5%19News CoveragePositive NewsAnalyst Forecast1.48%UTHRUnited Therapeutics$379.47-3.1%4.7214 of 5 stars2.69$423.85 11.7%13Trending NewsAnalyst ForecastInsider TradeShort Interest ↑1.40%NBIXNeurocrine Biosciences$138.03+1.4%4.8571 of 5 stars2.86$159.50 15.6%21Positive NewsShort Interest ↑1.19%BMRNBioMarin Pharmaceutical$56.71-3.8%4.9906 of 5 stars2.72$93.43 64.7%25News CoveragePositive NewsAnalyst Forecast1.15%MEDPMedpace$477.53-0.8%4.5197 of 5 stars1.94$412.73 -13.6%16News CoveragePositive NewsAnalyst DowngradeInsider Trade1.11%EXELExelixis$36.94-0.1%4.8099 of 5 stars2.52$44.06 19.3%23Analyst Revision1.08%GMABGenmab A/S$27.18+0.4%4.0419 of 5 stars2.64$37.60 38.3%11Positive News0.97%MRNAModerna$23.89-0.7%4.543 of 5 stars2.04$42.88 79.5%240.95%HALOHalozyme Therapeutics$74.19-0.8%4.6729 of 5 stars2.33$67.11 -9.5%12News CoverageAnalyst UpgradeInsider TradeAnalyst Revision0.91%TECHBio-Techne$52.91-0.8%4.992 of 5 stars2.75$70.42 33.1%12Positive NewsAnalyst Forecast This page (NASDAQ:IBB) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
